PT84860B - Processo para a preparacao de novos derivados do tetrahidronaftaleno e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados do tetrahidronaftaleno e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT84860B
PT84860B PT84860A PT8486087A PT84860B PT 84860 B PT84860 B PT 84860B PT 84860 A PT84860 A PT 84860A PT 8486087 A PT8486087 A PT 8486087A PT 84860 B PT84860 B PT 84860B
Authority
PT
Portugal
Prior art keywords
general formula
compounds
compound
preparation
tetrahydro
Prior art date
Application number
PT84860A
Other languages
English (en)
Portuguese (pt)
Other versions
PT84860A (en
Inventor
Michael Klaus
Peter Loerincz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT84860A publication Critical patent/PT84860A/pt
Publication of PT84860B publication Critical patent/PT84860B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
PT84860A 1986-05-13 1987-05-12 Processo para a preparacao de novos derivados do tetrahidronaftaleno e de composicoes farmaceuticas que os contem PT84860B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1938/86A CH668962A5 (de) 1986-05-13 1986-05-13 Tetrahydronaphthyl-propenyl-phenole.
CH74287 1987-02-26

Publications (2)

Publication Number Publication Date
PT84860A PT84860A (en) 1987-06-01
PT84860B true PT84860B (pt) 1990-02-08

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84860A PT84860B (pt) 1986-05-13 1987-05-12 Processo para a preparacao de novos derivados do tetrahidronaftaleno e de composicoes farmaceuticas que os contem

Country Status (20)

Country Link
CN (1) CN87103524A (nl)
AU (1) AU7277987A (nl)
BE (1) BE1001668A5 (nl)
DE (1) DE3715809A1 (nl)
DK (1) DK232087A (nl)
ES (1) ES2005572A6 (nl)
FI (1) FI872027A (nl)
FR (1) FR2598706B1 (nl)
GB (1) GB2190378B (nl)
HU (1) HU198002B (nl)
IL (1) IL82448A0 (nl)
IT (1) IT1203954B (nl)
LU (1) LU86866A1 (nl)
MC (1) MC1817A1 (nl)
NL (1) NL8701101A (nl)
NO (1) NO871961L (nl)
NZ (1) NZ220215A (nl)
PT (1) PT84860B (nl)
SE (1) SE8701933L (nl)
ZW (1) ZW6587A1 (nl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5475022A (en) * 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5534641A (en) 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1162200A (en) * 1981-02-13 1984-02-14 Michael Klaus Process for the manufacture of indanyl (or tetrahydronaphthyl)propenyl phenyl derivatives
EP0084667B1 (de) * 1982-01-23 1985-09-18 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
FI872027A0 (fi) 1987-05-07
NZ220215A (en) 1990-06-26
IL82448A0 (en) 1987-11-30
LU86866A1 (de) 1988-06-13
ES2005572A6 (es) 1989-03-16
GB8711205D0 (en) 1987-06-17
HU198002B (en) 1989-07-28
DE3715809A1 (de) 1987-11-19
FR2598706B1 (fr) 1990-07-06
ZW6587A1 (en) 1987-12-02
AU7277987A (en) 1987-11-19
DK232087D0 (da) 1987-05-06
NL8701101A (nl) 1987-12-01
IT8720232A0 (it) 1987-04-23
MC1817A1 (fr) 1988-03-18
IT1203954B (it) 1989-02-23
NO871961D0 (no) 1987-05-12
FI872027A (fi) 1987-11-14
GB2190378B (en) 1990-11-14
CN87103524A (zh) 1987-12-02
PT84860A (en) 1987-06-01
GB2190378A (en) 1987-11-18
HUT43806A (en) 1987-12-28
FR2598706A1 (fr) 1987-11-20
NO871961L (no) 1987-11-16
DK232087A (da) 1987-11-14
SE8701933D0 (sv) 1987-05-11
BE1001668A5 (fr) 1990-02-06
SE8701933L (sv) 1987-11-14

Similar Documents

Publication Publication Date Title
PT84860B (pt) Processo para a preparacao de novos derivados do tetrahidronaftaleno e de composicoes farmaceuticas que os contem
JP2516989B2 (ja) テトラヒドロナフタレン及びインダン誘導体
EP2186792B1 (en) 2-(a-hydroxypentyl) benzoate and its preparation and use
IL30394A (en) Phenylacetic acid derivatives
US4309442A (en) Method for controlling fertility in mammals
US3934034A (en) Hydroxy substituted diphenylalkyls for treatment of lipidemia
EP0098934A1 (en) 2-Methylseleno-benzamides
CS235548B2 (en) Method of tetrahydronaphthalene and indane new derivatives production
JPS6054379A (ja) 新規４ｈ−１−ベンゾピラン−４−オン誘導体，その製法および用途
JP5042015B2 (ja) 骨状態を治療するための治療薬としてのアリールアルキルスルホンアミド類
NO174848B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
US4855293A (en) Anti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether
CZ283779B6 (cs) Fenylhydrazony, způsob jejich výroby a kosmetické a farmaceutické přípravky z fenylhydrazonů
JPS638934B2 (nl)
US3821401A (en) Other publications
AU1359692A (en) N-((4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl) carbonyl)amino acids useful in the therapy of osteoarticular affections
JPS591474A (ja) ピペラジン環を有するゲラニルゲラニル酢酸アミド化合物またはその塩類
HU195480B (en) Process for preparing phenyl nonatetraenic acid derivatives
CS265240B2 (en) Process for preparing tetrahydrotetramethylnaphthylpropenylphenoles
HU216156B (hu) Eljárás indozilidinszármazékok előállítására, és a kiindulási vegyület
US3891699A (en) Biphenylenealkanoic acids
WO2000024393A1 (en) Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
WO1993019066A1 (en) Imidazopyridine derivative and medicine
US4062975A (en) Amino substituted arylthio-alkanoic acids having hypolipidemic activity
JPH0441134B2 (nl)

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19920106